Article Text


Original article
Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity
  1. Charlène Brault1,
  2. Pierre Lévy1,
  3. Sarah Duponchel1,
  4. Maud Michelet1,
  5. Aurèlie Sallé1,
  6. Eve-Isabelle Pécheur1,
  7. Marie-Laure Plissonnier1,
  8. Romain Parent1,2,
  9. Evelyne Véricel3,
  10. Alexander V Ivanov4,
  11. Münevver Demir5,
  12. Hans-Michael Steffen5,
  13. Margarete Odenthal6,
  14. Fabien Zoulim1,2,7,
  15. Birke Bartosch1,2
  1. 1Inserm U1052, Cancer Research Center of Lyon, University of Lyon, Lyon, France
  2. 2DevWeCan Laboratories of Excellence Network (Labex), France
  3. 3Université de Lyon, UMR 1060 INSERM CarMeN, IMBL, INSA-Lyon, Lyon, France
  4. 4Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
  5. 5Clinic for Gastroenterology and Hepatology, University Hospital of Cologne, Cologne, Germany
  6. 6Institute of Pathology, University of Cologne, Cologne, Germany
  7. 7Hospices civils de Lyon, Lyon, France
  1. Correspondence to Dr Birke Bartosch, Cancer Research Center of Lyon, 151 cours Albert Thomas, Lyon 69434, France; Birke.Bartosch{at}


Objective Inflammation and oxidative stress drive disease progression in chronic hepatitis C (CHC) towards hepatocellular carcinoma. HCV is known to increase intracellular levels of reactive oxygen species (ROS), but how it eliminates ROS is less well known. The role of the ROS scavenger glutathione peroxidase 4 (GPx4), induced by HCV, in the viral life cycle was analysed.

Design The study was performed using a replicative in vitro HCV infection model and liver biopsies derived from two different CHC patient cohorts.

Results A screen for HCV-induced peroxide scavengers identified GPx4 as a host factor required for HCV infection. The physiological role of GPx4 is the elimination of lipid peroxides from membranes or lipoproteins. GPx4-silencing reduced the specific infectivity of HCV by up to 10-fold. Loss of infectivity correlated with 70% reduced fusogenic activity of virions in liposome fusion assays. NS5A was identified as the protein that mediates GPx4 induction in a phosphatidylinositol-3-kinase-dependent manner. Levels of GPx4 mRNA were found increased in vitro and in CHC compared with control liver biopsies. Upon successful viral eradication, GPx4 transcript levels returned to baseline in vitro and also in the liver of patients.

Conclusions HCV induces oxidative stress but controls it tightly by inducing ROS scavengers. Among these, GPx4 plays an essential role in the HCV life cycle. Modulating oxidative stress in CHC by specifically targeting GPx4 may lower specific infectivity of virions and prevent hepatocarcinogenesis, especially in patients who remain difficult to be treated in the new era of interferon-free regimens.

View Full Text

Statistics from

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.